The Effect of Allopurinol on Insulin Resistance and Blood Pressure

NCT00639756 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome

Interventions

DRUG: Allopurinol
DRUG: Placebo

Sponsor

Hospital Mateo Orfila